Clinical Trial Details
EORTC-30781
Back to Clinical Trials Database
Doubled blind phase III trial of pyridoxine versus placebo in T1 Nx Mx and T1 No Mo transitional cell tumors of the bladder, after transurethral resection
| Trial Status | All trial activities ended |
|---|---|
| Data management at EORTC | |
| Design |
Phase 3 Randomized open label |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
